Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | VCAN |
| Upstream (Parents) |
|---|
| (<<) VIM → VCAN |
| (<<) THY1 → VCAN |
| (<<) SULF1 → VCAN |
| Downstream (Children) |
|---|
| VCAN → ZNF532 (>>) |
| VCAN → SHPK (>>) |
| VCAN → MMP14 (>>) |
| VCAN → MAGED4///MAGED4B (>>) |
| VCAN → SLC26A10 (>>) |
| VCAN → PLXDC1 (>>) |
| VCAN → VIM (>>) |
| VCAN → PTGS1 (>>) |
| VCAN → CHST1 (>>) |
| VCAN → DBN1 (>>) |
| VCAN → LAMB1 (>>) |
| VCAN → KAL1 (>>) |
| VCAN → DCLK1 (>>) |
| VCAN → TUBA1A (>>) |
| VCAN → EDIL3 (>>) |
| VCAN → ENTPD4///LOXL2 (>>) |
| VCAN → CYP1B1 (>>) |
| VCAN → MAP9 (>>) |
| VCAN → GSN (>>) |
| VCAN → DKFZp686O1327 (>>) |
| VCAN → PLXNC1 (>>) |
| VCAN → FZD2 (>>) |
| VCAN → ENDOG (>>) |
